Clinical Trial Update: Melphalan, Prednisone, Thalidomide and Defibrotide in Relapsed Multiple Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating a four-drug combination of melphalan, prednisone, thalidomide, and defibrotide in relapsed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan) (melphalan)
• Defitelio (defibrotide) (defibrotide)
• PREDNISONE (Prednisone)
• Thalomid (thalidomide) (thalidomide)

Snippet

Sponsor: Silvio Aime | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED